Of note, this may help explain the apparent discrepancy between the protective effects of IL-6 treatment in mitochondrial biogenesis and function and the beneficial roles of IL-6 deficiency in TG pool expansion. The gene discussed is IL6; the disease is hyperinsulinemic hypoglycemia, familial, 4.